Creatinine is a waste product generated from the normal breakdown of creatine, a compound involved in muscle energy production. It is produced at a relatively constant rate based on muscle mass and is filtered out of the blood by the kidneys, primarily through glomerular filtration.
Because creatinine is not significantly reabsorbed and only minimally secreted by the kidneys, it serves as a practical and widely used marker for assessing renal function. Serum creatinine levels are commonly used to estimate glomerular filtration rate (eGFR), which provides a broader view of kidney performance.
Evaluating creatinine levels helps clinicians assess kidney filtration capacity and detect early changes in renal function. It is commonly used to investigate:
• Kidney function and early renal impairment
• Acute or chronic kidney disease (CKD)
• Effects of medications that may impact renal function
• Hydration status and fluid balance
• Muscle mass and metabolic turnover (context-dependent)
• Cardiometabolic risk, as kidney function is closely tied to vascular health
Creatinine is often included in routine metabolic panels and is foundational for calculating eGFR.
Creatinine should not be interpreted in isolation. Because it is influenced by muscle mass, age, sex, and hydration status, pairing it with eGFR provides a more accurate assessment of kidney function. A “normal” creatinine does not always indicate optimal kidney health—particularly in individuals with low muscle mass, where values may appear deceptively low.
Trending creatinine over time is often more informative than a single measurement, especially when monitoring medication effects, cardiometabolic health, or early kidney decline. When abnormalities are identified, clinical focus typically shifts toward identifying contributing factors such as dehydration, hypertension, blood sugar dysregulation, medication use (e.g., NSAIDs), or underlying vascular and inflammatory conditions. Broader evaluation of renal and metabolic markers helps clarify whether changes reflect transient stress or progressive dysfunction.
• Men: ~0.7–1.3 mg/dL
• Women: ~0.6–1.1 mg/dL
• eGFR: >90 mL/min/1.73m² (optimal kidney function)
Note: Reference ranges vary by laboratory. In functional medicine, some providers may consider a narrower interpretive window to help guide clinical context. These values are not standardized and should be interpreted in conjunction with the ordering provider’s judgment.
“Patients with low muscle mass (common in aging, sarcopenia, or chronic illness) can have “normal” creatinine values that mask declining GFR, so always trend creatinine alongside cystatin C, BUN/creatinine ratio, and a simple spot urine Albumin-to-creatine ratio for true early detection of renal stress. This is clinically critical because subtle kidney decline often drives hypertension, insulin resistance, and cardiovascular risk long before eGFR drops below 90.”
Dr. Mitch Ghen
Disclaimer: Content on the Access Medical Labs blog is for informational purposes only and reflects the views of individual contributors, not necessarily those of Access Medical Labs. We do not endorse specific treatments, products, or protocols. This content is not a substitute for professional medical advice. Always consult a qualified healthcare provider regarding any medical concerns.